home / stock / avmxy / avmxy quote
Last: | $ |
---|---|
Change Percent: | 9.13% |
Open: | $7.97 |
Close: | $7.89 |
High: | $8.05 |
Low: | $7.83 |
Volume: | 528,505 |
Last Trade Date Time: | 09/30/2019 04:57:56 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $7.97 | $7.89 | $8.05 | $7.83 | 528,505 | 09-30-2019 |
$ | $7.50 | $7.23 | $7.50 | $7.22 | 286,770 | 09-27-2019 |
$ | $7.98 | $7.70 | $7.98 | $7.64 | 242,685 | 09-26-2019 |
$ | $8.06 | $7.98 | $8.06 | $7.94 | 124,461 | 09-25-2019 |
$ | $8.015 | $7.87 | $8.04 | $7.86 | 190,719 | 09-24-2019 |
$ | $7.88 | $7.775 | $8.01 | $7.65 | 343,295 | 09-23-2019 |
$ | $8.25 | $8.03 | $8.25 | $7.97 | 194,617 | 09-20-2019 |
$ | $8.20 | $8.29 | $8.58 | $8.10 | 266,178 | 09-19-2019 |
$ | $7.66 | $7.94 | $7.95 | $7.65 | 412,222 | 09-18-2019 |
$ | $7.115 | $7.28 | $7.30 | $7.115 | 117,601 | 09-17-2019 |
$ | $7.25 | $7.12 | $7.25 | $7.04 | 65,099 | 09-16-2019 |
$ | $7.31 | $7.12 | $7.31 | $7.02 | 64,774 | 09-13-2019 |
$ | $7.20 | $7.13 | $7.20 | $7.04 | 130,290 | 09-12-2019 |
$ | $7.205 | $7.03 | $7.33 | $6.985 | 49,002 | 09-11-2019 |
$ | $6.67 | $6.87 | $6.94 | $6.67 | 108,203 | 09-10-2019 |
$ | $6.94 | $6.815 | $6.94 | $6.79 | 158,077 | 09-09-2019 |
$ | $7.05 | $6.78 | $7.05 | $6.75 | 139,901 | 09-06-2019 |
$ | $7.16 | $7.19 | $7.24 | $7.15 | 307,000 | 09-05-2019 |
$ | $6.80 | $6.78 | $6.875 | $6.63 | 384,252 | 09-04-2019 |
$ | $6.045 | $6.17 | $6.26 | $5.95 | 80,361 | 09-03-2019 |
News, Short Squeeze, Breakout and More Instantly...
Avita Medical Company Name:
AVMXY Stock Symbol:
OTCMKTS Market:
Trading of American Depository Shares to begin under the ticker symbol “RCEL” on October 1st AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, annou...
Recent journal publications investigate the potential use of the RECELL System to treat multiple dermatological conditions AVITA Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company focused on the development and commercialization of innovative therapies leveraging the he...
First RECELL System clinical trial in the U.S. focused on acute soft tissue injuries, defects, and reconstruction; study expected to commence within next 6 months AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company focused on the development and commercialization of...